Moderna Retained Earnings (Accumulated Deficit) 2017-2025 | MRNA

Moderna retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $9.074B, a 27.01% decline year-over-year.

  • Moderna retained earnings (accumulated deficit) for 2024 were $10.045B, a 26.17% decline from 2023.
  • Moderna retained earnings (accumulated deficit) for 2023 were $13.606B, a 25.73% decline from 2022.
  • Moderna retained earnings (accumulated deficit) for 2022 were $18.32B, a 83.97% increase from 2021.

Moderna Retained Earnings (Accumulated Deficit) 2017-2025 | MRNA

  • Moderna retained earnings (accumulated deficit) for 2024 were $10.045B, a 26.17% decline from 2023.
  • Moderna retained earnings (accumulated deficit) for 2023 were $13.606B, a 25.73% decline from 2022.
  • Moderna retained earnings (accumulated deficit) for 2022 were $18.32B, a 83.97% increase from 2021.